☆ 4.0 Article

Design of the Empagliflozin Cardiovascular (CV) Outcome Event Trial in Type 2 Diabetes (T2D)

Canadian Journal of Diabetes (2013)

Journal

Canadian Journal of Diabetes

Volume 37, Issue -, Pages S29-S30

Publisher

Elsevier BV

DOI: 10.1016/j.jcjd.2013.08.088

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.